Atlas Trials

Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis

Clinical trial NCT02732405 · UNKNOWN

Trial details

NCT number
NCT02732405
Sponsor
Istituto Clinico Humanitas
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis CCompensated Cirrhosis
Start date
2016-05-01
Primary completion
2016-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.